OTC Markets OTCPK - Delayed Quote USD
Mesoblast Limited (MEOBF)
1.4300
0.0000
(0.00%)
At close: May 20 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in AUD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 6 | 6 |
| Avg. Estimate | 7.48M | 17.57M | 28.99M | 126.58M |
| Low Estimate | 7.48M | 17.57M | 20.48M | 92.12M |
| High Estimate | 7.48M | 17.57M | 40.39M | 225.6M |
| Year Ago Sales | -- | -- | 8.7M | 28.99M |
| Sales Growth (year/est) | -- | -- | 233.16% | 336.69% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MEOBF | -- | -- | -- | -- |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Related Tickers
1U5.BE WAVE Life Sciences Ltd
5.70
-1.72%
4BB.L 4basebio PLC
1,125.00
0.00%
RADX Radiopharm Theranostics Limited
4.3300
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
10.60
+3.31%
ATNF 180 Life Sciences Corp.
1.1500
0.00%
COGT Cogent Biosciences, Inc.
5.31
+6.63%
NRIX Nurix Therapeutics, Inc.
10.14
+6.62%
TLSA Tiziana Life Sciences Ltd
1.5000
+1.35%
TSVT 2seventy bio, Inc.
5.0000
0.00%
EWTX Edgewise Therapeutics, Inc.
14.87
+0.54%